Lavipharm Correlations
| LAVI Stock | EUR 0.72 0.01 1.37% |
The current 90-days correlation between Lavipharm SA and Intertech SA Inter is 0.14 (i.e., Average diversification). The correlation of Lavipharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Lavipharm Correlation With Market
Good diversification
The correlation between Lavipharm SA and DJI is -0.04 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Lavipharm SA and DJI in the same portfolio, assuming nothing else is changed.
Lavipharm |
The ability to find closely correlated positions to Lavipharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Lavipharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Lavipharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Lavipharm SA to buy it.
Moving together with Lavipharm Stock
| 0.82 | VIO | Viohalco SA | PairCorr |
| 0.82 | TPEIR | Piraeus Financial | PairCorr |
| 0.72 | ETE | National Bank | PairCorr |
| 0.9 | MIG | Marfin Investment | PairCorr |
| 0.86 | ELLAKTOR | Ellaktor SA | PairCorr |
Related Correlations Analysis
| 0.72 | 0.68 | 0.35 | 0.36 | 0.84 | 0.87 | INTET | ||
| 0.72 | 0.64 | 0.33 | 0.46 | 0.6 | 0.73 | OPTIMA | ||
| 0.68 | 0.64 | 0.58 | 0.54 | 0.6 | 0.72 | TELL | ||
| 0.35 | 0.33 | 0.58 | 0.29 | 0.2 | 0.49 | INKAT | ||
| 0.36 | 0.46 | 0.54 | 0.29 | 0.14 | 0.41 | IATR | ||
| 0.84 | 0.6 | 0.6 | 0.2 | 0.14 | 0.72 | OLYMP | ||
| 0.87 | 0.73 | 0.72 | 0.49 | 0.41 | 0.72 | LOGISMOS | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Lavipharm Stock performing well and Lavipharm Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Lavipharm's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| INTET | 1.53 | (0.30) | 0.00 | (0.66) | 0.00 | 4.12 | 12.49 | |||
| OPTIMA | 0.67 | (0.03) | 0.00 | 0.54 | 0.00 | 1.54 | 5.32 | |||
| TELL | 0.59 | (0.07) | 0.00 | 0.68 | 0.00 | 1.15 | 4.89 | |||
| INKAT | 0.85 | (0.10) | 0.00 | (0.24) | 0.00 | 1.87 | 7.66 | |||
| IATR | 1.01 | (0.06) | 0.00 | 3.45 | 0.00 | 2.60 | 9.13 | |||
| OLYMP | 0.91 | (0.10) | 0.00 | 6.94 | 0.00 | 2.09 | 5.43 | |||
| LOGISMOS | 0.64 | (0.20) | 0.00 | 1.13 | 0.00 | 1.49 | 5.58 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Lavipharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Lavipharm Corporate Management
Elected by the shareholders, the Lavipharm's board of directors comprises two types of representatives: Lavipharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lavipharm. The board's role is to monitor Lavipharm's management team and ensure that shareholders' interests are well served. Lavipharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lavipharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Katerina Fragioudakis | Head Chairman | Profile | |
| Vassilis Baloumis | Group CFO | Profile | |
| Panagiotis Giannouleas | COO Mang | Profile | |
| Spyridon Fotinos | Chief Officer | Profile | |
| Liana Dimitrakopoulou | Investor Officer | Profile | |
| Lucia Tweezers | VP Board | Profile | |
| Panagiotis Pavlou | Group Director | Profile |